DE2541484C3 - 1α-Alkyl-1 β-(2-cyanäthyl)- 1,2,3,4,6,7,12,12b β-octahydroindolo [2,3-a] chinolizine - Google Patents
1α-Alkyl-1 β-(2-cyanäthyl)- 1,2,3,4,6,7,12,12b β-octahydroindolo [2,3-a] chinolizineInfo
- Publication number
- DE2541484C3 DE2541484C3 DE2541484A DE2541484A DE2541484C3 DE 2541484 C3 DE2541484 C3 DE 2541484C3 DE 2541484 A DE2541484 A DE 2541484A DE 2541484 A DE2541484 A DE 2541484A DE 2541484 C3 DE2541484 C3 DE 2541484C3
- Authority
- DE
- Germany
- Prior art keywords
- acid
- general formula
- methanol
- cyanoethyl
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HURI545A HU169916B (US20020095090A1-20020718-M00002.png) | 1974-09-27 | 1974-09-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2541484A1 DE2541484A1 (de) | 1976-04-15 |
| DE2541484B2 DE2541484B2 (de) | 1981-06-04 |
| DE2541484C3 true DE2541484C3 (de) | 1982-04-15 |
Family
ID=11000956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2541484A Expired DE2541484C3 (de) | 1974-09-27 | 1975-09-17 | 1α-Alkyl-1 β-(2-cyanäthyl)- 1,2,3,4,6,7,12,12b β-octahydroindolo [2,3-a] chinolizine |
Country Status (20)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU499923B2 (en) * | 1975-06-27 | 1979-05-03 | Richter Gedeon Vegyeszeti Gyar N | Indoloquinolizine derivatives & their production |
| HU174502B (hu) * | 1976-12-30 | 1980-01-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh proizvodnykh oktagidro-indolo/2,3-a/-khinolizina |
| ZA786426B (en) * | 1977-11-25 | 1979-10-31 | Scras | New indulo(2,3-a)quinolizidines,preparation and therapeutic use |
| HU178700B (en) * | 1978-02-10 | 1982-06-28 | Richter Gedeon Vegyeszet | Process for preparing 1,1-disubstituted octahydro-indolo/2,3-a/-quinolizines |
| US4353911A (en) * | 1979-07-20 | 1982-10-12 | Andre Buzas | Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow |
| US5218119A (en) * | 1989-06-21 | 1993-06-08 | Richter Gedeon Vegyeszeti Gyar Rt. | Process for preparing the octahydro-indolo[2,3-a] quinolizine diester derivatives |
| CN107417595B (zh) * | 2017-03-27 | 2020-07-24 | 四川大学 | 一种基于自由基串联反应的系列单萜吲哚生物碱骨架及天然产物的合成方法 |
| US11083714B2 (en) | 2018-03-31 | 2021-08-10 | Molecular International Research, Inc. | Selective anti-cancer agent effective for prevention and treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3478051A (en) * | 1967-03-17 | 1969-11-11 | Sandoz Ag | Azecino- and azonino(5,4-b)indoles |
| US3536725A (en) * | 1967-11-22 | 1970-10-27 | Miles Lab | Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine |
| FR2108947B1 (US20020095090A1-20020718-M00002.png) * | 1970-10-22 | 1974-02-01 | Men Jean Le |
-
1974
- 1974-09-27 HU HURI545A patent/HU169916B/hu not_active IP Right Cessation
-
1975
- 1975-08-28 CA CA234,413A patent/CA1067495A/en not_active Expired
- 1975-09-02 IL IL48028A patent/IL48028A/xx unknown
- 1975-09-16 CH CH1207875A patent/CH619952A5/de not_active IP Right Cessation
- 1975-09-17 US US05/614,240 patent/US4057551A/en not_active Expired - Lifetime
- 1975-09-17 DE DE2541484A patent/DE2541484C3/de not_active Expired
- 1975-09-17 AT AT711375A patent/AT345995B/de not_active IP Right Cessation
- 1975-09-23 FR FR7529072A patent/FR2285877A1/fr active Granted
- 1975-09-23 CS CS756411A patent/CS226159B2/cs unknown
- 1975-09-24 NL NLAANVRAGE7511240,A patent/NL186383C/xx not_active IP Right Cessation
- 1975-09-25 YU YU2411/75A patent/YU40972B/xx unknown
- 1975-09-25 SE SE7510785A patent/SE421208B/xx not_active IP Right Cessation
- 1975-09-25 BG BG7531072A patent/BG31503A3/xx unknown
- 1975-09-25 DD DD188549A patent/DD121942A5/xx unknown
- 1975-09-26 JP JP50117085A patent/JPS5159898A/ja active Pending
- 1975-09-26 DK DK433275AA patent/DK139431B/da not_active IP Right Cessation
- 1975-09-26 PL PL1975183605A patent/PL100319B1/pl unknown
- 1975-09-26 GB GB39507/75A patent/GB1519050A/en not_active Expired
- 1975-09-26 SU SU2175647A patent/SU545260A3/ru active
- 1975-09-26 BE BE160441A patent/BE833897A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2453977A1 (de) | Neue ferrocen verbindungen und verfahren zu deren herstellung sowie pharmazeutische zusammensetzungen | |
| DE2541484C3 (de) | 1α-Alkyl-1 β-(2-cyanäthyl)- 1,2,3,4,6,7,12,12b β-octahydroindolo [2,3-a] chinolizine | |
| DE3020695C2 (US20020095090A1-20020718-M00002.png) | ||
| EP0155903A1 (de) | Indolophenanthridine, ihre Herstellung und Verwendung | |
| DE2539867C2 (de) | 14,15-Dihydro-3β ,16α -eburnameninderivate | |
| DE2757858C2 (US20020095090A1-20020718-M00002.png) | ||
| CH624955A5 (US20020095090A1-20020718-M00002.png) | ||
| DE2551952C3 (de) | 1,1-Disubstituierte Octahydroindolo [2,3-a] chinolizine | |
| DE2520131C3 (de) | 1,1,-Disubstituierte Octahydro-indolo[2,3-a]chinolizine und verfahren zu deren Herstellung | |
| DD141927A5 (de) | Verfahren zur herstellung von 1,1-disubstituierten octahydroindolo eckige klammer auf 2,3-a eckige klammer zu chinolizinen | |
| DE2733064C3 (de) | Vincan, seine Säureadditionssalze, solche Verbindungen enthaltende Arzneimittel sowie Verfahren zur Herstellung dieser Verbindungen | |
| DE2835987A1 (de) | 3-amino-17a-aza-d-homo-5 alpha -androstanderivate und quaternaere salze davon sowie verfahren zu ihrer herstellung | |
| DE2541485C3 (de) | 1-Alkyl-1-(2-cyanäthyl)-1,2,3,4,6,7-hexahydroindolo- [2,3-a] chinolizinderivate | |
| DE2733056C2 (de) | Vincamenin und seine Säureadditionssalze, solche enthaltende Arzneimittel sowie Verfahren zur Herstellung der genannten Verbindungen | |
| CH639638A5 (de) | Racemischer oder optisch aktiver alpha-(2,3,4-trimethoxyphenaethylaminomethyl)-2-hydroxybenzylalkohol und pharmazeutisch zulaessige saeureadditionssalze davon. | |
| DE2755511A1 (de) | N-propylnorapomorphin-diester | |
| AT214455B (de) | Verfahren zur Herstellung von neuen phosphorhaltigen Indolderivaten | |
| AT331247B (de) | Verfahren zur herstellung neuer 1,4-benzodioxan-derivate und ihrer salze | |
| AT221087B (de) | Verfahren zur Herstellung neuer, basischer Indol-Derivate | |
| DE2539866C2 (de) | 3,4-Dehydro-14,15-dihydro-eburnameninderivate | |
| DE2103134C3 (de) | 2-Aminoindazolo [1,2-b] phthalazin- 6-(11H), 13-dion, Verfahren zu dessen Herstellung sowie dieses enthaltende Arzneimittel | |
| DE2648208A1 (de) | Cuanzin-derivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, welche diese derivate enthalten | |
| DE2821226A1 (de) | Neue 5,6-dihydro-imidazo (5,1-a) isochinolin derivate und verfahren zu deren herstellung | |
| DE2627210A1 (de) | Neue benzophenonderivate | |
| DE1470155A1 (de) | Neue Pyrrolidinverbindungen,ihre Saeureadditionssalze,sowie Verfahren zu deren Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8339 | Ceased/non-payment of the annual fee |